Flow diagram of the multicentre NECT trial for treatment of 2^nd stage HAT.

<p>The diagram includes detailed information on excluded patients.</p

Baseline demographic, diagnostic and clinical characteristics of the patients, by centre.

<p>Baseline demographic, diagnostic and clinical characteristics of the patients, by centre.</p

Treatment compliance, length of hospitalisation and in-hospitalisation safety of NECT by sub-population of interest.

<p>HAT = Human African trypanosomiasis.</p>*<p>Calculated from day of admission to day of discharge.</p>†<p>Possibly or probably related to study drug.</p>‡<p>CTC grades 3–5.</p